Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


11-13 June 2019
Postillion Hotel Amsterdam,
Amsterdam, NL

Bringing you the latest science, technologies and partners needed to accelerate next generation antibodies towards commercial success

Join This List of Alumni from 2018

AB Studio Inc 


Ablynx NV 

Adaptimmune Ltd 

Aduro Biotech Europe 

Aelian Biotechnology 

AIMM Therapeutics 

Amgen Research Munich GmbH 

Amgen, Inc. 

Antikor Biopharma Ltd 

Aptevo Therapeutics 

Argen-X N.V. 


Boehringer Ingelheim 

Boehringer Ingelheim Pharmaceutical Inc. 

Celyad S.A. 


Christian-Albrechts-University Kiel 

ChromoTek GmbH 

CHRU Besancon/ITAC platform 


CureVac AG 

Elasmogen Ltd 

EPO Berlin-Buch GmbH (EPO) 



ETH Zurich 

ETH Zurich/Swiss Federal Institute of Te 

Experimental Biotherapeutics Centre

FairJourney Biologics 

Garvan Institute of Medical Research 

Genentech, Inc. 

Genmab BV 

Ghent University 

Gilead Sciences 

Ginkgo Bioworks 

Goshen College 

Gustave Roussy Cancer Centre  

Institute of Molecular & Cell Biology 


Kagoshima University 

Karolinska Institutet 

Kookmin University 

Kyowa Hakko 



Leiden University 

Leiden University Medical Center 



Nestle Skin Health 

Nestle Skin Health/Galderma RandD 

Novimmune SA 


Prothix B.V. 

Radboud Institute for Molecular Life Sci 

Ragon Institute of MGH, MIT and Harvard 

Roche Innovation Center Zurich


Sanofi Aventis R & D 

Shemyakin and Ovchinnikov Institute of B 


Symphogen AS 

Tagworks Pharmaceuticals 

Taipei Medical University 

Takis Srl 

The Harley Street Clinic 

The Netherlands Cancer Institute 

TheraPharm Deutschland GmbH 

Tohoku University 

TU-Braunschweig, Dep. Biotechnology 

UCB UCb Celltech 

UCL Cancer Institute 


Utrecht University College London 

University Hospital of Erlangen 

University Medical Center Hamburg-Eppend 

University of Cologne 

University of Oxford 

University of Southampton 

University of Zurich 

Uppsala University 

Utrecht University 

WuXi Biologics 

Y-mAbs Therapeutics, Inc. 


Zymeworks Inc

By the Numbers

Leading Academic and Industry Scientists
Innovative Presentations by World-Renowned Speakers
Poster Presentations to Discover New, Unpublished Methods and Data

Submit a Poster at Antibody Engineering & Therapeutics

Share your company's new research by presenting a poster at Antibody Engineering & Therapeutics Europe. Posters should be in PORTRAIT orientation and no larger than 1m wide x 1.5m high.

Please note that all poster presenters must be registered attendees.  

More information regarding posters will be forthcoming.

Call for Speaker is Now Open!

If you are working in any of the following scientific/business topic areas, we encourage you to submit a proposal for a podium presentation. We are especially looking for case studies with new data on the following:

- New Antibody Formats and Effector Functions
- Antibody Therapeutics for Autoimmune and Neurodegenerative Diseases
- Turning Antibody Leads into Drugs
- T Cell Engineering with Antibodies
- Bioinformatics and Repertoires in Antibody Discovery and Development
- Clinical Developments in Antibody Therapeutics
- Bispecific Antibodies: New Strategies and Case Studies
- Antibody-drug Conjugates (ADCs): New Strategies and Case Studies

Deadline to submit a proposal is 21 December 2018

Become an Event Sponsor or Exhibitor

Showcase your products and services to antibody scientists and executives. To request a floor plan, or to see a list of available package options, please contact Aimee Croke at or +1-857-504-6697 or Kristin Skahan at or +1-857-504-6730.

About The Antibody Society

The Antibody Society is an international, non-profit representing individuals and organizations involved in antibody-related research and development. The Society has a variety of initiatives and working groups focused on improving the antibody field.

We are:

- Creating opportunities for education and networking;

- Monitoring and reporting advances in the commercial pipeline for antibody and CAR-T therapeutics;

- Creating standards for characterizing antibody and T-cell receptor repertoires, and engaging this field;

- Engaging government and international agencies on matters concerning the antibody community;

 Please join us!